The role of immune responses to haemagglutininneuraminidase (HN) protein in protection against a Newcastle disease virus (NDV) infection was investigated using a recombinant vaccinia virus expressing HN (HN-RVV). Live HN-RVV replicated in chickens and completely protected them from lethal infection with virulent NDV. Inactivated HN-RVV also protected chickens when administered with adjuvant but not when administered without adjuvant. However, large amounts of the inactivated HN-RVV (100-fold excess) without adjuvant provided protection. Specific antibodies against the HN protein of NDV were detected in sera from survivors but not from dying birds. However, the kinetics of antibody responses in chickens inoculated with live HN-RVV and inactivated HN-RVV were considerably different. These results clearly confirm that immune response(s) solely to the HN protein of NDV can provide chickens with protection against NDV challenge, and show that the presence of antibodies to the HN protein correlates significantly with the protection from NDV infection at least in HN-immunized chickens.
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Newcastle disease virus (NDV) is the prototype paramyxovirus and the causative agent of Newcastle disease (ND). NDV bears two major surface glycoproteins, the haemagglutinin-neuraminidase (HN) and fusion (F) proteins, on its envelope (Nagai et al., 1976; Alexander & Collins, 1981; Sato, 1987) . These surface glycoproteins were reported to play key roles in the course of NDV infection (Giraudon & Wild, 1985; Wolinsky et al., 1985) . Recently, by using recombinant poxviruses expressing the F protein of NDV, the immune response(s) to the F protein was shown to provide protective immunity against NDV infection in chickens (Meulemans et al., 1988; Boursnell et al., 1990a) . Further, Boursnell et al. (1990b) reported the protective effect of HN protein against NDV infection by a recombinant fowlpox virus (FPV, FP9 strain) expressing the HN protein of NDV strain Beaudette C. They showed that the recombinant FPV provides good levels of protection in spite of the induction of low levels of antibody before NDV challenge. However, no study on the kinetics of the antibody response after challenge was made in detail. In the present study, we confirm that NDV HN alone protects against NDV infection and show that the presence of haemagglutination-inhibiting (HI) antibody in HN-immunized chickens correlates significantly with survival from NDV infection by using a recombinant vaccinia virus expressing the HN protein of NDV (HN-RVV), including the inactivated one.
The HN-RVV was constructed essentially according to Mackett et al. (1984) . This recombinant vaccinia virus carries a cDNA encoding the entire sequence of the HN protein of NDV strain Miyadera (Gotoh et al., 1988) downstream of a promoter, P7.5, within its thymidine kinase gene. Expression of the HN protein in and on the surface of chicken embryo fibroblast cells infected with HN-RVV was confirmed by indirect immunofluorescence and radioimmunoprecipitation by using monoclonal antibodies specific to the HN of NDV (Hoshi et al., 1983 , and data not shown).
Inoculation of the live HN-RVV (8 × 106 p.f.u./bird) was by scarification of the comb of 8-to 9-week-old specific pathogen-free (SPF) chickens (Line LMG), which were hatched and reared in isolators in our laboratory. The chickens developed 10 to 40 pustules on the inoculated site 2 clays post-inoculation (p.i.) as * Eight-to 9-week-old chickens were inoculated with HN-R'qV or wild-type vaccinia virus in a 0.1 ml suspension. $ Chickens were challenged 4 weeks p.i. by intratracheal inoculation with a 0.1 ml suspension of NDV strain Sato. :~ Doses of inactivated HN-RVV were expressed as p.f.u, equivalents. § Subcutaneous inoculation.
described previously (Webster et al., 1988) . By immunohistochemical examination using a Vectastain ABC kit (Vector Laboratories), the HN protein was detected only in the inoculated area of the combs from 1 to 7 days p.i. In order to examine the protective effect of HNspecific immune response(s), 8-to 9-week-old chickens that had been inoculated with the supernatants of homogenized chorioallantoic membranes including live HN-RVV or wild-type vaccinia virus (WR strain, kindly provided by Dr S. Kato, Osaka University) were intratracheally challenged with a lethal dose (8 x 104 p.f.u, or 8 x 102 p.f.u./bird) of virulent NDV Sato strain 4 weeks later. As shown in Table 1 , the chickens inoculated with live HN-RVV were completely protected from this NDV challenge, although all of the chickens inoculated with wild-type vaccinia virus died. NDV was isolated from the trachea and intestine of the dead birds which showed specific symptoms of ND. These results clearly indicate that the immune response(s) to the HN of NDV alone is sufficient to protect chickens from NDV challenge as described previously (Boursnell et al., 1990b) .
The protective effect of inactivated HN-RVV was also examined (Table 1 ). The supernatants of homogenized chorioallantoic membranes including HN-RVV of 8 x 106 or 8 × 108 p.f.u, were inactivated by flpropiolactone according to the procedure described by Wiktor et al. (1972) . All the chickens inoculated with the inactivated HN-RVV (equivalent to 8 x 106 p.f.u./bird) died, although the same dose of live HN-RVV induced protective immunity against NDV challenge. However, inoculation of chickens with either an increased dose of inactivated HN-RVV (equivalent to 8 x 108 p.f.u./bird) or with inactivated HN-RVV (equivalent to 8 x 106 p.f.u./bird) mixed with an equal amount of Freund's complete adjuvant provided protective effects against NDV challenge. The survivors were apparently normal for 2 weeks after challenge, and NDV could not be isolated from these birds 2 weeks post-challenge. These results may indicate that protection from NDV infection requires a significant level of immune response(s) to the HN protein. Fig. 1 shows typical results of the kinetics of antibody production during the challenge experiments. The antibody titre was measured by an HI test (Sever, 1962) . HI antibodies were induced in chickens after both the inoculation of HN-RVV and challenge with NDV, but the titres varied between individual chickens (Fig. I a  to d) . On the other hand, inoculation with inactivated HN-RVV did not induce or induced an undetectable level of HI antibodies before challenge with virulent NDV (Fig. I e to h ). Among chickens inoculated with inactivated HN-RVV, those which produced HI antibodies survived and those which did not produce or produced an undetectable level of antibodies died after challenge. Specific antibody responses detected by ELISA (Kida et al., 1982) in these chickens were similar to those determined by the HI test (data not shown).
Considered together, the chickens that produced detectable levels of HI antibodies before or after NDV challenge survived, regardless of whether the HN-RVV was live or inactivated. HN-RVV was more effective live than inactivated for protection and in antibody induction. Possible reasons for this are that the quantity and/or duration of antigen stimulation by HN may be different between live and inactivated HN-RVV inoculations since the live HN-RVV could replicate in chickens, and the manner of antigen presentation of HN may be different between live and inactivated HN-RVV inoculations, because only in the former case was HN synthesized in the infected cells of inoculated chickens. Umino et al. (1987 Umino et al. ( , 1990 reported that passive immunization with HN-specific antisera conferred poor protection against NDV infection. Protection from NDV infection by HI antibodies may require a relatively large quantity of antibodies. Immunization with a lower dose of inactivated HN-RVV which resulted in poor protection supports this concept. Boursnell et al. (1990b) also reported dose-dependent protection by immunization of recombinant FPV expressing HN of NDV. Live recombinant vaccinia viruses were reported to induce not only specific antibodies but also cellular immune responses (Bennink et al., 1984) . In the course of the study, we observed a chicken that survived a low dose of NDV challenge (8 x 102 p.f.u./bird) without any detectable level of HI antibodies (data not shown). However, our results indicated that the protection correlated significantly with the presence of HI antibody even after NDV challenge. It is possible that the antibody level in the serum might reflect the overall level of immunity in the chicken, and cell-mediated immune responses against HN protein may play a critical role in protective immunity. The role of cellular immunity to the HN protein in protection from NDV infection is now under investigation using HN-RVV.
